BioSpace News Archive

Omeprazole Market: Duodenal ulcers segment dominated the market

Omeprazole, a drug belonging to proton pump inhibitors class, is used to decrease the amount of acid produced in the stomach.

March 10, 2021
·
4 min read
Merkel Cell Carcinoma (MCC) Treatment Market: Radiation is a rapidly growing segment

Merkel cell carcinoma is a rare disease in which malignant cancer cells form in the skin. Merkel cell carcinoma is the second most common cause of skin cancer death after melanoma.

March 10, 2021
·
5 min read
Plasma Thawing System Market: Dual basket plasma thawing system segment is propelling the market

Plasma thawing is the process of allowing the frozen plasma to stand at ambient temperature that is above zero degree Celsius.

March 10, 2021
·
5 min read
Sleeping Medications Market: Rising prevalence of sleep disorders to drive the market

Sleeping medications are commonly known as sleeping pills. Sleeping pills mainly refers to a generic term used for describing both over-the-counter or prescription medications.

March 10, 2021
·
4 min read
XPhyto Partner Receives ISO Certification for 25-Minute COVID-19 RT-PCR Test

XPhyto Therapeutics Corp., and its exclusive German diagnostics development partner, 3a-diagnostics GmbH, are pleased to announce successful EN ISO 13485 certification for the rapid point-of-care, SARS-CoV-2 RT-PCR Test System.

March 10, 2021
·
4 min read
InDex Pharmaceuticals presents at Barclays Global Healthcare Conference and Carnegie Nordic Virtual Healthcare Seminar

InDex Pharmaceuticals Holding AB announced that CEO Peter Zerhouni will present the company at Barclays Global Healthcare Conference on Thursday March 11, 2021 and at Carnegie Nordic Virtual Healthcare Seminar on Friday March 12, 2021, both at 13:30 CET.

March 10, 2021
·
2 min read
Pharm Country

Teleflex to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Jake Elguicze, Treasurer and Vice President of Investor Relations, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Wednesday, March 24, 2021 at 9:15am (ET).

March 10, 2021
·
1 min read
Business

Establishment Labs Reports Fourth Quarter and Full Year 2020 Financial Results; Record Fourth Quarter Revenue of $27.0 Million

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the fourth quarter and full year ended December 31, 2020 and provided initial 2021 guidance.

March 10, 2021
·
9 min read
Biotech Beach

CURE Pharmaceutical Announces Addition of Two New Clinical Development Programs Targeting Anti-Seizure and Antiviral Applications

CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has launched two new clinical development programs and added new corresponding products to its growing pharmaceutical pipeline.

March 10, 2021
·
5 min read
BioCapital

Embody Advances Biologic Augmentation Market with First-Of-Its-Kind Collagen Implant

Embody, Inc., a privately-held medical device company developing novel collagen-based technologies for soft tissue injury and repair, announced today the expansion and clinical use cases of TAPESTRY® Biointegrative Implant in the U.S. market.

March 10, 2021
·
2 min read